Methods of treating whsc1-overexpressing cancers by inhibiting setd2
US-2025360103-A1 · Nov 27, 2025 · US
Thomenius Michael is listed as an inventor on 13 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Thomenius Michael |
| Total patents | 13 |
| First publication | Oct 31, 2019 |
| Latest publication | Nov 27, 2025 |
Publications ranked by popularity score, then publication date.
US-2025360103-A1 · Nov 27, 2025 · US
US-12116358-B2 · Oct 15, 2024 · US
US-2024180919-A1 · Jun 6, 2024 · US
US-2024139203-A1 · May 2, 2024 · US
US-11952572-B2 · Apr 9, 2024 · US
US-11786533-B2 · Oct 17, 2023 · US
US-2023075198-A1 · Mar 9, 2023 · US
US-2023049113-A1 · Feb 16, 2023 · US
US-2022288085-A1 · Sep 15, 2022 · US
US-2022105098-A1 · Apr 7, 2022 · US
Latest publications not already listed above.
US-11147819-B2 · Oct 19, 2021 · US
US-2021002645-A1 · Jan 7, 2021 · US
US-2019328743-A1 · Oct 31, 2019 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Epizyme Inc | 13 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 13 |
| A61K45/06 | 9 |
| A61K31/5377 | 9 |
| A61K31/4439 | 8 |
| A61K9/0053 | 7 |